Yahoo Finance

Sonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™, First Braided Self-Expanding Cerebral Venous Stent, to Treat Debilitating Pulsatile Tinnitus

LAKE FOREST, Calif., Feb. 5, 2026 /PRNewswire/ -- Sonorous Neurovascular, a pioneering medical device company dedicated to advancing neurovascular therapies, today announced that the U.S. Food and ...
Yahoo Finance

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment of venous sinus stenosis, today announced the ...

Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH(TM) Neurovascular Catheter

Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) ...
MarketWatch

Serenity Medical Receives U.S. FDA HDE Approval of the River(TM) Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

The MarketWatch News Department was not involved in the creation of this content. Landmark regulatory milestone makes the River stent available for adults with severe IIH -- a debilitating, ...
Seeking Alpha

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

SAN MATEO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular ...
manilatimes

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

Publication in the Journal of NeuroInterventional Surgery Reports Outcomes for Treatment of IIH Patients Who Are Refractory or Intolerant to Medications HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) ...
Business Insider

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy Serenity Medical ...